Vanadium administration ameliorates cortical structural and functional changes in juvenile hydrocephalic mice.
Funmilayo Eniola Olopade1, Omowumi Moromoke Femi-Akinlosotu1, Opeyemi Dauda1
1Department of Anatomy, College of Medicine, University of Ibadan, Ibadan, Nigeria.
The Journal of Comparative Neurology
|January 4, 2024
Summary
Vanadium treatment improved motor function and reduced brain damage in juvenile hydrocephalic mice. This suggests vanadium
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- Hydrocephalus is a significant neurological burden, especially in Africa, with current treatments like shunting having complications.
- Alternative, drug-based therapies are needed for hydrocephalus due to shunting limitations.
- Vanadium, a neurotoxic metal, shows potential therapeutic benefits in neurological conditions.
Purpose of the Study:
- To investigate the neuroprotective effects of varying vanadium doses on motor and cerebellar cortices in juvenile hydrocephalic mice.
- To assess the impact of vanadium on neurobehavioral deficits and cytoarchitectural changes in hydrocephalus.
Main Methods:
- Hydrocephalus was induced in juvenile mice using intracisternal kaolin injection.
- Vanadium (0.15, 0.3, 3.0 mg/kg) was administered intraperitoneally for 28 days.
- Neurobehavioral tests (open field, hanging wire, pole test) and histological analyses (NeuN, GFAP staining) were performed.
Main Results:
- Hydrocephalic mice showed impaired motor function and significant neurodegeneration with reactive astrogliosis.
- Vanadium treatment improved motor deficits and mitigated neuronal damage and astrogliosis in a dose-dependent manner.
- High-dose vanadium showed persistent astrogliosis, indicating a complex dose-response relationship.
Conclusions:
- Vanadium administration demonstrates neuroprotective potential in a mouse model of hydrocephalus.
- Vanadium may offer a viable therapeutic strategy for hydrocephalus, warranting further investigation into its molecular mechanisms.
- The study highlights the need for careful dose optimization in vanadium-based therapies.


